Thermal sensitization using induced oxidative stress decreases tumor growth in an in vivo model of hyperthermic intraperitoneal perfusion

Annals of Surgical Oncology

Volumn 17, Issue 1, 2010, Pages 304-311

  Razavi, Reza ^a   Harrison, Lawrence E ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; TERT BUTYL HYDROPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CANCER CELL; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IN VITRO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; OXIDATIVE STRESS; PERFUSION; SURVIVAL; TUMOR GROWTH;

ANIMALS; CARCINOMA; CELL PROLIFERATION; COLONIC NEOPLASMS; DNA DAMAGE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROGEN PEROXIDE; HYPERTHERMIA, INDUCED; INJECTIONS, INTRAPERITONEAL; MICE; MICE, NUDE; OXIDANTS; OXIDATIVE STRESS; SURVIVAL RATE; TERT-BUTYLHYDROPEROXIDE; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 74649085012     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0674-3     Document Type: Article

References (28)

1. P Carraro M Segala B Cesana G Tiberio 2001 Obstructing colonic cancer: failure and survival patterns over a ten-year follow-up after one-stage curative surgery Dis Colon Rectum 44 243 250 10.1007/BF02234300 1:STN:280: DC%2BD3M7ot1Sktg%3D%3D 11227942
2. D Jayne S Fook C Loi F Seow-Choen 2002 Peritoneal carcinomatosis from colorectal cancer Br J Surg 89 1545 1550 10.1046/j.1365-2168.2002.02274.x 1:STN:280:DC%2BD38noslajtA%3D%3D 12445064 (Pubitemid 35404323)
3. D Elias F Blot A El Otmany, et al. 2001 Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy Cancer 92 71 76 10.1002/1097-0142(20010701)92: 1<71::AID-CNCR1293>3.0.CO;2-9 1:STN:280:DC%2BD3Mvgs12itA%3D%3D 11443611 (Pubitemid 32623042)
4. BW Loggie RA Fleming RP McQuellon, et al. 2000 Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin Am Surg 66 561 568 1:STN:280:DC%2BD3M%2Fhs1ahsg%3D%3D 10888132
5. P Shen EA Levine J Hall, et al. 2003 Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis Arch Surg 138 26 33 1:CAS:528:DC%2BD3sXos1eqtg%3D%3D 12511145 (Pubitemid 36055643)
6. VJ Verwaal S van Ruth E de Bree, et al. 2003 Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 3737 3743 10.1200/JCO.2003.04.187 14551293 (Pubitemid 46606227)
7. GC Li NF Mivechi G Weitzel 1995 Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia Int J Hyperthermia 11 8 459 10.3109/02656739509022483 1:CAS:528:DyaK28Xns1Wmsw%3D%3D
8. F Chen R Razavi CC Wang LE Harrison 2008 Proteasome inhibition potentiates the cytotoxic effects of hyperthermia in HT-29 colon cancer cells through inhibition of heat shock protein 27 Oncology 73 98 103 10.1159/000120997
9. C Wang F Chen E Kim LE Harrison 2007 Thermal sensitization through ROS modulation: a strategy to improve the efficacy of hyperthermic intraperitoneal chemotherapy Surgery 142 384 392 10.1016/j.surg.2007.03.013 17723891 (Pubitemid 47302035)
10. F Chen C Wang L Harrison 2008 Hyperthermia combined with t-BOOH induces autophagic cell death and retardation of S phase in HT-29 colon cancer cells Cell Biol Int 32 715 723 10.1016/j.cellbi.2008.02.010 1:CAS:528: DC%2BD1cXms1Wqu7w%3D 18396422
11. DE Jenkins Y Oei YS Hornig, et al. 2003 Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis Clin Exp Metastasis 20 733 744 10.1023/B:CLIN.0000006815.49932.98 1:CAS:528:DC%2BD3sXpsV2ktbw%3D 14713107 (Pubitemid 38019275)
12. SK Calderwood A Asea 2002 Targeting HSP70-induced thermotolerance for design of thermal sensitizers Int J Hyperthermia 18 597 608 10.1080/ 0265673021000019666 1:CAS:528:DC%2BD3sXit1Chuw%3D%3D 12537758 (Pubitemid 35469191)
13. RA Lockshin Z Zakeri 2004 Apoptosis, autophagy, and more Int J Biochem Cell Biol 36 2405 2419 10.1016/j.biocel.2004.04.011 1:CAS:528: DC%2BD2cXmvFemu78%3D 15325581 (Pubitemid 39119755)
14. P Jacquet AD Stephens AM Averbach, et al. 1996 Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy Cancer 77 2622 2629 10.1002/(SICI)1097-0142(19960615)77:12<2622::AID-CNCR28>3.0.CO;2-T 1:STN:280:DyaK283jvFeltg%3D%3D 8640714 (Pubitemid 26169161)
15. PR Wachsberger R Burd A Bhala, et al. 2003 Quercetin sensitizes cells in a tumour-like low pH environment to hyperthermia Int J Hyperthermia 19 507 519 10.1080/0265673031000078697 1:CAS:528:DC%2BD3sXmvVWgtLw%3D 12944166 (Pubitemid 37138728)
16. Y Arai T Kondo K Tanabe, et al. 2002 Enhancement of hyperthermia-induced apoptosis by local anesthetics on human histiocytic lymphoma U937 cells J Biol Chem 277 18986 18993 10.1074/jbc.M108084200 1:CAS:528:DC%2BD38XktFCht7g%3D 11861640 (Pubitemid 34952461)
17. IB Shchepotin RR Buras RJ Nauta, et al. 1994 Effect of mitomycin C, verapamil, and hyperthermia on human gastric adenocarcinoma Cancer Chemother Pharmacol 34 257 260 10.1007/BF00685086 1:STN:280:DyaK2c3ntlarsg%3D%3D 8004760
18. CM Rudin Z Yang LM Schumaker, et al. 2003 Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance Cancer Res 63 312 318 1:CAS:528:DC%2BD3sXnt1Kksg%3D%3D 12543781
19. RA Miller KW Woodburn Q Fan, et al. 2001 Motexafin gadolinium: a redox active drug that enhances the efficacy of bleomycin and doxorubicin Clin Cancer Res 7 3215 3221 1:CAS:528:DC%2BD3MXnvF2rs74%3D 11595717
20. IV Lebedeva ZZ Su D Sarkar 2005 et al. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis Oncogene 24 585 596 10.1038/sj.onc.1208183 1:CAS:528:DC%2BD2MXltVSgsQ%3D%3D 15580305 (Pubitemid 40188563)
21. SR Pestieau KJ Schnake OA Stuart PH Sugarbaker 2001 Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy Cancer Chemother Pharmacol 47 269 276 10.1007/s002800000214 1:CAS:528:DC%2BD3MXjtlGrtrk%3D 11320672 (Pubitemid 32640763)
22. S Kusamura E Dominique D Baratti, et al. 2008 Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy J Surg Oncol 98 247 252 10.1002/jso.21051 18726886
23. B Hildebrandt P Wust O Ahlers, et al. 2002 The cellular and molecular basis of hyperthermia Crit Rev Oncol Hematol 43 33 56 10.1016/S1040-8428(01) 00179-2 12098606 (Pubitemid 34722786)
24. B Celicout H Levard J Hay, et al. 1998 Sclerosing encapsulating peritonitis: early and late results of surgical management in 32 cases French Associations for Surgical Research. Dig Surg 15 697 702 1:STN:280: DyaK1M%2Fmt1WktQ%3D%3D
25. H Aihara H Maruoka H Kiyozaki F Konishi 2003 Sclerosing encapsulating peritonitis (SEP) as a delayed complication of continuous hyperthermic peritoneal perfusion (CHPP): report of a case Surg Today 33 232 236 10.1007/s005950300052 12658394 (Pubitemid 36363635)
26. A Shido S Ohmura K Yamamoto, et al. 2000 Does hyperthermia induce peritoneal damage in continuous hyperthermic peritoneal perfusion? World J Surg 24 507 511 10.1007/s002689910081 1:STN:280:DC%2BD3c3ks1Onug%3D%3D 10787067 (Pubitemid 30210836)
27. MA Le Bitoux I Stamenkovic 2008 Tumor-host interactions: the role of inflammation Histochem Cell Biol 130 1079 1090 10.1007/s00418-008-0527-3 18953558
28. C Kamate S Baloul S Grootenboer, et al. 2002 Inflammation and cancer, the mastocytoma P815 tumor model revisited: triggering of macrophage activation in vivo with pro-tumorigenic consequences Int J Cancer 100 571 579 10.1002/ijc.10519 1:CAS:528:DC%2BD38Xlslyjsbc%3D 12124807 (Pubitemid 34816158)